HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Mastocytosis — Clinical Guidelines

Overview

Mastocytosis is a disorder characterized by the abnormal accumulation of clonal mast cells in various organs, primarily affecting the skin in pediatric cases and often systemic in adults, with significant clinical manifestations due to mediator release and organ involvement 1 5.

Diagnosis

Key Diagnostic Criteria: Presence of mast cell infiltration in affected tissues, often identified by skin lesions (e.g., urticaria pigmentosa) 1 3.

Recommended Tests: Histopathological examination of biopsy samples, bone marrow biopsy for systemic involvement, allele-specific quantitative PCR (ASqPCR) for KIT mutations 1.

Grading: Classification into cutaneous, indolent systemic, smoldering systemic, aggressive systemic, and mast cell leukemia based on extent of organ involvement and disease progression 5.

Management

First-Line Treatments: Avoidance of triggers (physical, medications), symptomatic relief with antihistamines (H1 and H2 blockers) 1 7.

Adjunctive Treatments: Cladribine for refractory cases in adults, with careful monitoring of efficacy and safety 4.

Specific Therapies: Management tailored to individual patient needs, considering molecular defects like KIT D816V and additional mutations (TET2, SRSF2, etc.) 5.

Special Populations

Pediatrics: Focus on cutaneous manifestations; strict avoidance protocols for triggers; use of sedation and analgesia with caution in dental settings 1 7.

Comorbidities: Close monitoring for complications such as hepatosplenomegaly and gastrointestinal bleeding, especially in diffuse cutaneous forms like bullous mastocytosis 1 8.

Key Recommendations

Utilize ASqPCR for detecting KIT mutations in peripheral blood to monitor disease progression and clonal expansion (Evidence: Moderate) 1.

Implement strict avoidance strategies for known triggers to minimize mast cell degranulation and associated symptoms (Evidence: Expert opinion) 1.

Tailor treatment approaches based on disease classification (cutaneous vs systemic) and molecular profile, considering advanced therapies like cladribine for refractory cases (Evidence: Moderate) 4 5.

References

1 Schaffer JV. Pediatric Mastocytosis: Recognition and Management. American journal of clinical dermatology 2021. link 2 Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O et al.. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts. Theranostics 2020. link 3 Hartmann K, Escribano L, Grattan C, Brockow K, Carter MC, Alvarez-Twose I et al.. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. The Journal of allergy and clinical immunology 2016. link 4 Akin C. Cladribine for mastocytosis: benefits and risks. Blood 2015. link 5 Valent P. Diagnosis and management of mastocytosis: an emerging challenge in applied hematology. Hematology. American Society of Hematology. Education Program 2015. link 6 Melton GB. Milt Shore: editor and advocate. The American journal of orthopsychiatry 2014. link 7 Nelson LP, Savelli-Castillo I. Dental management of a pediatric patient with mastocytosis: a case report. Pediatric dentistry 2002. link 8 Golitz LE, Weston WL, Lane AT. Bullous mastocytosis: diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme. Pediatric dermatology 1984. link 9 Griffiths WA, Daneshbod K. Pseudoxanthomatous mastocytosis. The British journal of dermatology 1975. link

Mastocytosis